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Background: Evidence suggests that patients with bipolar disorder from the United States have an earlier
age of onset and a more difﬁcult course of illness than those from Germany and the Netherlands. These
characteristics were related to a greater family burden of psychiatric illness and the experience of more
psychosocial adversity in childhood. We hypothesized that this greater illness burden would extend to
the offspring of the US patients.
Methods: 968 outpatients (average age 41) with bipolar illness gave informed consent for participation in a
treatment outcome network and ﬁlled out a detailed questionnaire about their illness and family history of
illness, including whether their offspring had a diagnosis of depression, bipolar disorder, alcohol or substance
abuse, suicide attempt or “other” illness. Of those with children, 356 were from the US and 132 were from
Europe.
Results: Compared to the Europeans, offspring of patients from the US had signiﬁcantly (po0.001) more
depression, bipolar disorder, drug abuse, and “other” illnesses. The number of illnesses in the offspring was
related to the bipolar parent being from the US, having had childhood adversity, more than 20 prior episodes,
and more parental psychiatric illness.
Conclusions: While the ﬁndings are limited by their basis on self report, the distribution of the percentages in
the US offspring are similar to those of Axelson et al. (2015) who used direct interviews. The higher burden of
illness in the offspring and their in direct progenitors from the US compared to Europe warrant new attempts
at better treatment and prevention.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Contents1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 181
2. Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 181
3. Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 181
4. Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 183B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
twork, Bethesda, MD, USA.
Post).
R.M. Post et al. / Journal of Affective Disorders 191 (2016) 180–186 1814.1. Caveats, limitations and counter arguments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 183
4.2. Clinical Implications . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 184
Acknowledgments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 185
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1851. Introduction
Compared to Europeans patients with bipolar disorder from the
United States (US) have an earlier age of onset of their illness
(Bellivier et al., 2014; Etain et al., 2012; Post et al.,
2014b,2011,2014a). Across multiple studies an early age of onset is
associated with a more difﬁcult or severe course of illness (Bir-
maher et al., 2009,2014; Carlson et al., 2002; Carter et al., 2003;
DelBello et al., 2007; Ernst and Goldberg, 2004; Perlis et al., 2004;
Post et al., 2014b,2014a,2010b), and accordingly, patients from the
US have a higher incidence of factors associated with a poor
prognosis, including: childhood adversity; anxiety and substance
abuse comorbidity, rapid cycling, and more with 20 or more prior
episodes, as well as poor response to long term naturalistic
treatment (Post et al., 2014b).
Earlier age of onset and more severe illness characteristics appear
to have a genetic/familial basis as parents and grandparents of the US
patients have more mood and substance abuse disorders than these
relatives of the European patients, and this burden of illness in the
family is associated with an earlier age of onset and more difﬁcult
illness course in our bipolar probands (Post et al., 2015).
Given these ﬁndings we hypothesized that the offspring of the
bipolar patients for the US would have a higher incidence of these
same illnesses that characterized the prior generations (i.e., the
probands parents, and their grandparents) than those from the
Netherlands and Germany. These included depression, bipolar
disorder, suicide attempts, alcohol abuse and substance abuse, and
“other” illnesses. We also hypothesized the more difﬁcult illness
characteristics in the patients themselves would be associated
more illness in the offspring.Table 1
Demographics of parents' adverse bipolar illness characteristics (what have been
termed poor prognosis factors, or PPFs).
US
(n¼356)
Europe
(n¼132)
chi p
% positive % positive
Early onset 68.8 37.1 40.4 0.00
Childhood abuse 70.8 46.2 25.3 0.00
Number of episodes 60.7 27.3 43.0 0.00
Rapid cycling 75.8 47.0 36.9 0.00
Anxiety disorder 48.3 28.8 15.0 0.00
Drug or alcohol abuse 50.0 25.8 23.0 0.00
Parental history or uni or bipolar
disorder
60.1 37.9 19.2 0.00
% positive is the precent of probands positive for the listed ppf in the speciﬁed
country.
Statistic is a chi square.2. Methods
968 outpatients (average age 41) with bipolar disorder (75% BP
I) diagnosed by SCID interview were recruited from advertise-
ments and local clinics in four cities in the United States (Los
Angeles, Dallas, Cincinnati, Bethesda) and three in Europe
(Utrecht, the Netherlands and Freiburg and Munich, Germany)
from 1995 to 2002. Patients gave informed consent for participa-
tion in the network and completed self-rated questionnaires on
family history, psychosocial adversity in childhood, and their ret-
rospective course of illness (Leverich et al., 2002; Post et al.,
2014b,2013a,2010a,2014a,2010b).
The following diagnoses were queried on the offspring: uni-
polar depression, bipolar disorder, history of a suicide attempt or
completed suicide, alcohol abuse, drug abuse, and “other illness”
including for example an anxiety disorder. Each diagnosis of a
family member was rated by the proband as deﬁnite, likely, un-
likely, or not present, and a deﬁnite or likely rating was taken as a
positive diagnosis for that relative (Post et al., 2014b,2014a). The
questionnaire also elicited answers pertaining to the adult pa-
tients’ demographics, stressors in childhood, and course of illness
characteristics, including the age of onset of bipolar disorder. This
was described as the age of onset of the ﬁrst major depression
associated with dysfunction or the ﬁrst manic or hypomanic epi-
sode. Stressors in childhood included a total score for the report of
verbal, physical, and sex abuse, each rated as never¼0, rarely¼1,occasionally¼2, and frequently¼3 (Leverich et al., 2002; Post
et al., 2014c).
Patients were asked about the number of offspring that they
had and whether the offspring had any of the above diagnoses.
488 patients indicated that they had children. Of these 356 were
from the US and 152 were from Europe. Age of the children was
not elicited, and age of onset of the psychiatric disorders they may
have had was not obtained.
The incidence of the psychiatric difﬁculties in the offspring of
those from the US was compared with those from Europe by chi-
square test and po0.05 was considered signiﬁcant. The presence
or absence of each type of illness in the offspring was related to
their parents’ (the proband) illness characteristics by a chi-square,
except where a low N required a Fisher's Exact Test. These char-
acteristics included: early onset (before age 19); presence of any
abuse in the proband’s childhood; a history of rapid cycling (4 or
more episodes/year) and 20 or more episodes prior to Network
entry; a history of any anxiety disorder, alcohol, or drug abuse
comorbidity; and a positive family history of psychiatric illness in
the proband’s parents.
A linear regression with robust standard errors was run on the
proband’s adverse illness characteristics (poor prognosis factors,
PPFs) to see whether they were independently related to the
number of psychiatric diagnoses their offspring had (Table 2). After
examing parents ppf’s on the total number of child psychiatric di-
agnoses we looked at each psychiatric diagnosis separately. For each
psychiatric diagnosis a logistic regression was run to see the re-
lationship of each of the speciﬁed diagnoses to their parents PPFs,
and each regression is reported for each offspring illness in Table 3
(A)–(F). Table 4 illustrates the independent effect of being from the
US as opposed to Europe when all of the patient differences in PPFs
were taken into account. It summarizes the results of 6 separate
regressions and only reports on the independent effect of country.3. Results
The demographics of the parents who had children (N¼488)
were very similar to those in the entire network (N¼968) and are
summarized in Table 1. Each of what might be considered a poor
Table 3
Relationship of bipolar patients' illness poor prognosis factors (PPFs) to illness
occurring in their offspring.
Child's depression diagnosis in absence or presence
of parental PPF
3A
Parents illness PPF p No PPF n¼389 PPF n¼99
Early onset 0.031 15.5% 23.5%
Childhood abuse 0.014 14.3% 23.6%
20þepisodes 0.00 12.3% 27.8%
Rapid cycling 0.002 12.2% 24.1%
Anxiety 0.00 13.7% 29.1%
Alcohol or drug abuse 0.497 19.2% 21.7%
Parental history 0.00 12.1% 27.3%
3B
Child's bipolar dx
p No PPF n¼422 PPF n¼66
Early onset 0.002 7.7% 17.4%
Childhood abuse 0.198 10.9% 15.0%
20þepisodes 0.001 8.1% 18.7%
Rapid cycling 0.022 8.3% 16.0%
Anxiety 0.001 9.0% 19.5%
Alcohol or drug abuse 0.723 13.0% 14.2%
Parental history 0.00 6.7% 19.3%
3C
Child's suicide attempt
p No PPF n¼462 PPF n¼26
Early onset 0.582 4.6% 5.8%
Childhood abuse 0.008 1.7% 7.4%
20þepisodes 0.065 3.4% 7.1%
Rapid cycling 0.062 2.6% 6.6%
Anxiety 0.05 3.6% 7.6%
Alcohol or drug abuse 0.271 4.4% 6.6%
Parental history 0.046 3.1% 7.2%
3D
Child's alcohol abuse
p No PPF n¼459 PPF n ¼29
Early onset 0.076 3.6% 7.5%
Childhood abuse 0.00 0.6% 9.0%
20þepisodes 0.001 2.1% 9.5%
Rapid cycling 0.351 4.5% 6.6%
Anxiety 0.173 4.7% 7.6%
Alcohol or drug abuse 0.817 6.2% 5.7%
Parental history 0.005 2.7% 8.7%
3E
Child's drug abuse
p No PPF n¼460 PPF n¼48
Early onset 0.205 11.2% 7.7%
Childhood abuse 0.00 2.9% 13.7%
20þepisodes 0.001 5.1% 14.3%
Rapid cycling 0.039 5.8% 11.8%
Anxiety 0.051 7.6% 12.9%
Alcohol or drug abuse 0.203 8.3% 11.8%
Parental history 0.032 6.7% 12.5%
3F
Child's “Other” diagnosis
p No PPF n-388 PPF n¼100
Early onset 0.00 12.4% 25.9%
Childhood abuse 0.00 8.0% 27.5%
20þepisodes 0.00 10.6% 29.8%
Rapid cycling 0.00 9.6% 25.6%
Anxiety 0.00 12.2% 31.4%
Alcohol or drug abuse 0.563 19.6% 21.7%
Parental history 0.007 15.2% 25.0%
Table 2
Logistic Regression for the Number of illnesses in the offspring as predicted by
probands' poor prognosis factors (N¼488).
Odds
ratio
Std.
err.
z p [95% conf. interval]
Country -0.39 0.08 -4.78 0.000 0.56 0.23
Age of onset 0.00 0.00 0.18 0.855 0.01 0.01
Childhood
abuse
0.29 0.09 3.26 0.001 0.12 0.47
Number of
episodes420
0.37 0.11 3.43 0.001 0.16 0.59
Anxiety
disorder
0.30 0.12 2.6 0.010 0.07 0.53
Parental history 0.29 0.10 2.91 0.004 0.10 0.49
The number of illnesses in the offspring was signiﬁcantly related to each PPF with
the exception of early Age of Onset of bipolar disorder
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highly signiﬁcantly more prevalent in the US than in the Nether-
lands or Germany (Europe). These patients had an average of 1.97
and a median of 2 offspring, and this did not differ between those
from the US versus Europe.
The burden of offspring illness was substantial and included
20.3% with depression, 13.5% with bipolar disorder, 5.3% with a
suicide attempt, 5.9% with alcohol abuse, 9.8% with drug abuse,
and 20.5% with “other” illness. As shown in Fig. 1, compared to
Europeans the offspring of patients with bipolar illness from the
US had signiﬁcantly more of each diagnosis (po0.001), with the
exception of a history of alcohol abuse (p,0.01), or suicide attempt
(ns) and schizophrenia where the incidence of these in the off-
spring was low.
Table 2 illustrates the linear regression with robust standard
errors of the number of diagnoses in the offspring as related to
parental illness characteristics F (6,481)¼13.17, po0.001. The
parents emanating from the US as opposed to Europe, having had
abuse during childhood, having had 20 or more episodes, an an-
xiety disorder comorbidity, and more psychiatric illness in their
parents (the grandparents of the offspring) were signiﬁcantly in-
dependently related to the number of diagnoses in the offspring.
Neither the proband’s income level or level of educational at-
tainment related to the presence or absence of the offsping’s di-
agnosis of depression or bipolar disorder (data not illustrated).
As illustrated in Table 3 each type of psychiatric difﬁculty in the
offspring was related to various aspects of the patients’ (parents’)
illness characteristics as described in the paragraph below. In ad-
dition in Table 4 is the summary of six logistic regressions in-
dicating that the country of origin (US vs Europe) was signiﬁcantly
related to each of the offspring’s difﬁculties independently of any
of the parent’s illness characteristics, listed in Table 3.
The occurrence of depression (3A) or an “other” diagnosis (3F) in
the offspring was signiﬁcantly related to the presence of each of the
adverse illness characteristics (poor prognosis factors) in the pro-
band, with the exception of alcohol or drug abuse. Very similarly, a
diagnosis of bipolar disorder in the offspring (3B) was related to the
probands’ early onset, more episodes and rapid cycling, anxiety
disorder comorbidity, and a positive parental history of psychiatric
illness, but not a history of alcohol or substance abuse and in this
instance not the parents’s history of abuse in childhood.
Interestingly, even with the very small numbers of offspring
positive for a suicide attempt (3C), this was signiﬁcantly related to
the probands’ own history of abuse in childhood (p¼0.008), an
anxiety disorder comorbidity (p¼0.05), and the patients' parents
positive history of psychiatric illness (p¼0.046).
Fig. 1. The total sample of all patients who responded to whether their child had a
disorder was 488; of these 356 were from the US and 132 were from Europe.
Table 4
Inﬂuence of Country on disorders in children of bipolar patients controlling for proband ppfs*
OR SE z p [95% conf. interval] Regression N Regression LR Regression p
Depression 0.43 0.16 -2.3 0.022 0.21 0.88 488 46.53 0.00
Bipolar 0.29 0.15 -2.46 0.014 0.11 0.78 488 41.39 0.00
Suicide 0.62 0.42 -0.71 0.48 0.16 2.36 488 15.15 0.0563
Alcohol 0.35 0.28 -1.31 0.19 0.07 1.69 488 36.19 0.00
Drug 0.27 0.17 -2.08 0.038 0.08 0.93 488 33.09 0.0001
Other 0.28 0.12 -2.94 0.003 0.12 0.65 488 74.41 0.00
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offspring were both related to a history of the parents history of
abuse in childhood (po0.001), the occurrence of 20 or more
episodes (p¼0.001), and the parental loading for psychiatric ill-
ness, but interestingly not the probands’ history of either type of
substance abuse.
Table 4 summarizes the results of 6 separate regressions illus-
trating that offspring in the US compared to Europe had sig-
niﬁcantly more of each type of illness (except suicide attempt)
even after all of the differences in the patients PPFs were taken
into account.4. Discussion
Each psychiatric diagnosis was more common in the offspring
of patients with bipolar illness from the US compared to those
from the Netherlands or Germany (for convenience abbreviated
here as Europe). Particularly striking were the high levels and
signiﬁcant US vs Europe differences in the offsprings’ incidence of
depression (25% vs. 8%), bipolar disorder (17% vs. 4%), and “other”
psychiatric disorders (26% vs. 5%) and drug abuse (12% vs 2%),.
The number of illnesses in the offspring was also signiﬁcantly
related to country (US4Germany and the Netherlands). This dif-
ference remained signiﬁcant even when the other poor prognosis
factors were taken into account in the linear regression in Table 2.
Most of the probands’ poor prognosis factors (with the notable
exception of drug or alcohol abuse comorbidity) were signiﬁcantly
related to an increased incidence of offspring depression, bipolar
disorder, and “other” illness in the whole sample. These included;
the patient’s own parental history of psychiatric illness, an earlyage of onset (before age 19), a history of an anxiety disorder co-
morbidity, and 20 or more episodes and rapid cycling. A history of
abuse in childhood was related to depression and “other” illness in
the offspring, but not to bipolar disorder in the offspring. When
separate logistic regressions were run including country as well as
all other illness characteristics (poor prognosis factors) of the
parents, in each instance the greater amounts of illness in the
offspring in the US compared to Europe were signiﬁcant (Table 4)
and could not be explained by any of the difference in the patients
poor prognosis factors (listed in Table 1)
The relationship of more severe illness characteristics in the
adult patient (probands) themselves to the occurrence of depres-
sion, bipolar, and “other” illness in the offspring suggest strong
transgenerational transmission of not only bipolar disorder, but
also depression and “other” psychiatric illness in the offspring.
These ﬁndings are consistent with our previous observations that
parents and grandparents of the US probands had more psychia-
tric illness burden than the European probands (Post et al., 2014a),
and that this total family loading was associated with an earlier
age of onset of bipolar disorder in the probands (Post et al., 2015).
The occurrence of psychosocial adversity in the proband’s
childhood was likewise higher in the US than Europe (Post et al.,
2013a), and this interacted with the degree of family loading to
convey the earliest ages of onset of bipolar disorder in our pro-
bands (Post et al. 2015). The proband’s early age of onset was re-
lated to their offsprings diagnoses of depression, bipolar disorder,
and “other” illness, but early age of onset was not a predictor of
the overall number of illnesses the offspring had in the multiple
regression. This relationship of parental early onset illness to the
occurrence of bipolar illness in the offspring is consistent with the
ﬁndings of (Preisig et al., 2015) that early onset bipolar disorder
(and not bipolar disorder in general) was the signiﬁcant risk factor
for the offspring in their study to develop bipolar disorder.
4.1. Caveats, limitations and counter arguments
Before with further discussing these ﬁndings and their poten-
tial implications, several caveats are in order. Most of the data
presented rest on answers by the proband to a detailed patient
questionnaire and were not directly cross validated by other
sources.
However, a number of factors in the literature suggest that
these ﬁnding are likely valid. Most telling are the recent ﬁnding of
Axelson et al. (2015) in high risk children (because of a parent with
bipolar disorder) who had increased risk of bipolar spectrum
disorder, depression, anxiety and other disorders compared to
community controls upon a 6.7 year prospective follow up with
systematic diagnositic assessments. The incidence of these dis-
orders was even higher in the offspring in the Axelson et al. (2015)
study compared to our offspring. While our study and that of
Axelson et al. (2015) are not directly comparable in age of the
children, duration of time of observation or follow up, or methods
of diagnosis, the ﬁndings show substantial similarities in the
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disorders. In our study, a positive offspring diagnosis was counted
only once even in families with 2 or more children suggesting that
the percent of illness in the individual children of our patients
could be somewhat lower than stated.
The ﬁndings also bare some similarity to those in other pro-
spective high risk studies in the literature conducted in the US
which showed a higher incidences of childhood onset bipolar
disorder than those conducted in Canada, the Netherlands, or
Switzerland (Post et al., 2014b). In the review of epidemiological
studies of childhood onset bipolar disorder, Van Meter et al. (2011)
found higher rates of bipolar disorder in the US than many other
countries when studies that included BP-NOS in the assessments
were compared.
The very substantially earlier age of onset of bipolar disorder in
the US in our studies (Post et al., 2014b,2008) have been replicated
by others (Bellivier et al., 2014; Post et al., 2008). The earlier the
age of onset of illness in our patients (probands) was associated
with higher incidence of a diagnosis of bipolar disorder, as well as
depression and “other” illness in the offspring.
4.2. Clinical Implications
Given the data from studies in the literature in addition to our
own reported here, there is considerable evidence that bipolar
illness in the US has an earlier age of onset and more adverse
course than in many other countries. In addition there appears to
be an excess of family history positivity for a number of illnesses in
4 generations of those from the US compared to Germany and the
Netherlands. In particular a substantial portion of a new genera-
tion of offspring from parents with bipolar illness have already
progressed from an “at high risk” status to already having multiple
actual difﬁcult-to-treat childhood disorders as seen here and in
the study of Axelson et al. (2015) and the other high risk studies
particularly in the US but also in Europe.
This large burden of illness is also consistent with the ﬁndings
supporting the existence of a year of birth or cohort effect where
each generation from the early 1900s has had an increased in-
cidence and earlier age of onset of unipolar and bipolar disorder
(Lange and McInnis, 2002). A cohort effect is also present for
ADHD where there is a higher incidence in more recently born
children that in older children, an effect that is not related to
differences in diagnostic criteria (Thomas et al., 2015). Thus, pe-
diatricians and psychiatrists need to play a key role not only re-
cognizing the impact of childhood adversity on subsequent med-
ical and psychiatric illness (Shonkoff and Garner, 2012), but also of
the range of psychiatric illnesses beginning in childhood and
adolescence in both high risk and community-based populations
(Axelson et al., 2015) that require careful evaluation, treatment,
and referral if necessary.
This transgenerational transmission in our results and in the
literature would appear to have both genetic and environmental
(epigenetic) bases. As in the classic cross-fostering studies of
Meaney and associates (Weaver et al., 2004,2006), the biochemical
and behavioral signature of high licking and grooming dams is
passed to the next generation based on the licking and grooming
behavior the pups received and not on genetic inheritance of
traits. In addition to these well-accepted environmental experi-
ence-induced epigenetic mechanisms, new data suggest the pos-
sibility of a third form of transmission, where a father’s lifetime
experience with and reactivity to stressors and some drugs of
abuse is passed on to the next generation in the absence of any
contact with the offspring. These altered behavioral reactivities are
thought to be mediated by the persistence of epigenetic chemical
marks on the gametes (ova and sperm) that are passed to the next
generation (Bale, 2014; Dias and Ressler, 2014; Szutorisz et al.,2014; Vassoler et al., 2014). This mechanism is of particular in-
terest in relationship to the ﬁndings in our study of the parents’
own experience of abuse in childhood being related to the oc-
currence of each diagnosis in the offspring (except bipolar dis-
order) as well as to the number of psychiatric difﬁculties in the
offspring.
Whatever the precise genetic, neurobiological, and psychoso-
cial mechanisms of transgenerational transmission, this problem
of a high multigenerational increased illness burden in the US
deserves replication with more precise prospective measures and
epidemiologically sound methodology, as well as attempts at
amelioration and prevention. Miklowitz et al. (2013) reported that
high risk children by virtue of a positive family history of bipolar
disorder who had a diagnosis of depression, anxiety, or cyclothy-
mia did signiﬁcantly better with family focused therapy (FFT) than
treatment as usual (TAU) in most aspects if symptomology and the
effects were the largest in families with high negative expressed
emotion. Thus it would appear that FFT or some related therapy
(Fristad et al., 2009) would be of great importance in approaching
early mood and anxiety symptoms that may or not be precursors
to bipolar disorder (Axelson et al., 2015). Since early childhood
onsets of unipolar and bipolar disorder both have a less positive
outcome than adult onset illness (Birmaher et al., 2009,2014;
Carlson et al., 2002; Carter et al., 2003; DelBello et al., 2007;
Ernst and Goldberg, 2004; Perlis et al., 2004; Post et al.,
2014b,2014a,2010b) at least in part driven by the increased dura-
tion of time lag before treatment is commenced (Post et al.,
2010b), approaching this lag as a remediable risk factor deserves
special attention.
Little systematic data are available to guide clinical therapeutics
in childhood bipolar disorder or in the youngest children who
often present with BP-NOS, which is itself is highly disabling,
difﬁcult to treat, and a precursor to full bipolar in about 50% of the
children who also have a positive family history of bipolar disorder
(Axelson et al., 2015; Birmaher et al., 2009). A new vital treatment
research agenda is indicated, so that the very large groups of
children who have the multiple illnesses seen in our US cohort and
that of Axelson et al. (2015) and others (Birmaher et al., 2009,2014;
Perlis et al., 2004; Post et al., 2015,2010) have the best information
for optimized care. There are multiple safe candidate agents that
could readily be studied in practical (open randomized) clinical
trials including omega 3 fatty acids (Nemets et al., 2006; Wozniak
et al., 2007) (Ratheesh and McGorry, 2014), vitamin D3 (Gracious
et al., 2012), N-acetylcysteine (Berk et al., 2013; Hardan et al.,
2012), and perhaps even EM Power, and minocycline that could be
explored (Post et al., 2013) in parallel to studies of agents already
found effective in adults.
In light of the paucity of data about how very young child with
mood and behavioral disorders are currently being treated in the
community, we have started a Child Mood Disorder Initiative for
parents of children (2–12) with these illnesses (or at risk for them
by virtue of a positive parental history of a mood disorder) to rate
the severity of symptoms on a weekly basis on a secure web site.
The observational protocol is approved by the IRB of John Hopkins
School of Medicine in collaboration with the PI Robert Findling.
Information about the Network and an informed consent docu-
ment are available at www.bipolarnews.org. Parents will be able to
print out the longitudinal weekly ratings of depression, anxiety,
ADHD, oppositional behavior and mania which should assist them
and their child’s clinicians in better deﬁning illness course and
response to treatment. We hope this Child Network will add a
modicum of treatment-related knowledge in very young children
as the ﬁeld awaits more systematic data from randomized studies.
In the meantime the message from our studies and those in the
literature is that in addition to a general trend in the population
seen in the cohort effect, children at high risk for illness because of
R.M. Post et al. / Journal of Affective Disorders 191 (2016) 180–186 185a positive family history of bipolar, especially in the US but also
elsewhere, deserve special attention, monitoring, and in many
instances speciﬁc treatment for their varied disorders. With early
recognition and intervention, these illnesses will hopefully have a
more benign course (Correll et al., 2007; McNamara et al., 2010;
Post, 2009; Post et al., 2013c; Post and Kowatch, 2006; Ratheesh
and McGorry, 2014).Acknowledgments
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